一个关于透析治疗方式绝对和相对指示的最新情况
1School of Medicine, Faculty of Medicine and Health Sciences, Keele University, UK.
Clinical kidney journal
|September 15, 2023
概括
对于大多数患者来说,腹腔透析存活率在腹腔透析 (PD) 和血液透析 (HD) 模式之间是相似的. 患者的偏好应该指导选择,因为禁忌是罕见的.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 脏替代疗法治疗 脏替代疗法
- 透析方式 透析方式
背景情况:
- 选择透析方式对于末期脏病患者至关重要.
- 选择应基于临床指示,有利于特定的治疗方法.
研究的目的:
- 更新关于选择透析方式的指导意见.
- 分析生存,模式转换和影响因素.
主要方法:
- 用高层次结果,提供者级因素和患者级因素的框架进行文献综述.
- 考虑腹腔透析 (PD) 和血液透析 (HD) 的亚型.
主要成果:
- 存活率通常独立于治疗方式,包括糖尿病患者.
- 观察到PD和家庭HD的改善生存率,特别是在较少的并发症患者中.
- 提供者对禁忌 (例如,肥胖,APKD) 的偏见往往没有得到结果的支持.
结论:
- 透析方式的绝对禁忌并不常见.
- 存在相对指示,但患者的偏好在决策中至关重要.
相关概念视频
Dialysis
353
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
353
Acute Kidney Injury V: Interprofessional Care
25
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
25
Hemodialysis III: Nursing Management
49
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
49
Hemodialysis I: Introduction
51
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
51
Chronic Kidney Disease III: Interprofessional Care
41
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
41
Hemodialysis II: Procedure and Complications
41
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
41


